Fonds de solidarité FTQ — 2024 Investments
4 investments dated 2024 · listed companies and verified rows first · show all
Ability.ai builds AI agents that automate repetitive, rule-based workflows across business functions like customer support, HR, marketing, sales, finance, and IT, which customers deploy on their own platform called Trinity.
AI & Machine LearningDeveloper ToolsEnterprise SoftwareSaaSSales TechSan Francisco, US
Eugene Vyborov(Founder and CEO)in
Co-investorsSID Venture Partners1991 VenturesAlexandria
Epitopea develops off-the-shelf cancer vaccines targeting aberrantly expressed tumor-specific antigens using its proprietary CryptoMap platform.
AI & Machine LearningBiotechHealthtechMontreal, CA
Claude PerreaultPierre Thibault
Co-investorsAdvent Life SciencesCambridge Innovation CapitalCTI Life Sciences Fund L.P.adMare BioInnovations
Feldan is a clinical-stage biotech company developing intracellular delivery technologies for therapeutic treatment of diseases.
BiotechDeep TechMedical Devices
François-Thomas Michaud(Board Member & Chief Executive Officer)in
Co-investorsAsahi Kasei Corporate Venture CapitalGenesys CapitalLinearis VenturesZynext Ventures
Flare provides a searchable, structured dataset of dark web forums, marketplaces, and Telegram channels for cybercrime investigations and threat intelligence.
AI & Machine LearningCybersecurityData & InfrastructureEnterprise SoftwareSaaS
Norman MenzinJohn WilliamsoninAlex Hooper(Founder)Colin Mierowsky(Founder)Daniel Cohen(Founder)Daniel Parekh-Hill(Founder)
Co-investorsLuge Capital20VC4Di CapitalANOBAKABase10 PartnersBorderless Venture+8 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.



















